460 related articles for article (PubMed ID: 34202192)
1. Ceramide Metabolism and Parkinson's Disease-Therapeutic Targets.
Custodia A; Aramburu-Núñez M; Correa-Paz C; Posado-Fernández A; Gómez-Larrauri A; Castillo J; Gómez-Muñoz A; Sobrino T; Ouro A
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34202192
[TBL] [Abstract][Full Text] [Related]
2. Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases.
Custodia A; Romaus-Sanjurjo D; Aramburu-Núñez M; Álvarez-Rafael D; Vázquez-Vázquez L; Camino-Castiñeiras J; Leira Y; Pías-Peleteiro JM; Aldrey JM; Sobrino T; Ouro A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897658
[TBL] [Abstract][Full Text] [Related]
3. Ceramide synthases as potential targets for therapeutic intervention in human diseases.
Park JW; Park WJ; Futerman AH
Biochim Biophys Acta; 2014 May; 1841(5):671-81. PubMed ID: 24021978
[TBL] [Abstract][Full Text] [Related]
4. A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways.
Pewzner-Jung Y; Park H; Laviad EL; Silva LC; Lahiri S; Stiban J; Erez-Roman R; Brügger B; Sachsenheimer T; Wieland F; Prieto M; Merrill AH; Futerman AH
J Biol Chem; 2010 Apr; 285(14):10902-10. PubMed ID: 20110363
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents.
Giles C; Takechi R; Mellett NA; Meikle PJ; Dhaliwal S; Mamo JC
J Neurochem; 2017 May; 141(3):413-422. PubMed ID: 28129448
[TBL] [Abstract][Full Text] [Related]
6. Astrocytic ceramide as possible indicator of neuroinflammation.
de Wit NM; den Hoedt S; Martinez-Martinez P; Rozemuller AJ; Mulder MT; de Vries HE
J Neuroinflammation; 2019 Feb; 16(1):48. PubMed ID: 30803453
[TBL] [Abstract][Full Text] [Related]
7. Ceramide synthases at the centre of sphingolipid metabolism and biology.
Mullen TD; Hannun YA; Obeid LM
Biochem J; 2012 Feb; 441(3):789-802. PubMed ID: 22248339
[TBL] [Abstract][Full Text] [Related]
8. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins.
Hammad SM; Twal WO; Arif E; Semler AJ; Klein RL; Nihalani D
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32045989
[TBL] [Abstract][Full Text] [Related]
10. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
[TBL] [Abstract][Full Text] [Related]
11. Role of Ceramides and Sphingolipids in Parkinson's Disease.
Vos M; Klein C; Hicks AA
J Mol Biol; 2023 Jun; 435(12):168000. PubMed ID: 36764358
[TBL] [Abstract][Full Text] [Related]
12. Expression of Ceramide Synthases in Mice and Their Roles in Regulating Acyl-Chain Sphingolipids: A Framework for Baseline Levels and Future Implications in Aging and Disease.
Richardson WJ; Humphrey SB; Sears SM; Hoffman NA; Orwick AJ; Doll MA; Doll CL; Xia C; Hernandez-Corbacho M; Snider JM; Obeid LM; Hannun YA; Snider AJ; Siskind LJ
Mol Pharmacol; 2024 Feb; 105(3):131-143. PubMed ID: 38164625
[TBL] [Abstract][Full Text] [Related]
13. Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases.
Raichur S
Front Endocrinol (Lausanne); 2020; 11():483. PubMed ID: 32849276
[TBL] [Abstract][Full Text] [Related]
14. Drug Development in the Field of Sphinogolipid Metabolism.
Qu Z; Zhou L
Adv Exp Med Biol; 2022; 1372():169-188. PubMed ID: 35503181
[TBL] [Abstract][Full Text] [Related]
15. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
[TBL] [Abstract][Full Text] [Related]
16. The long and the short of ceramides.
Wattenberg BW
J Biol Chem; 2018 Jun; 293(25):9922-9923. PubMed ID: 29934368
[TBL] [Abstract][Full Text] [Related]
17. The Link between Gaucher Disease and Parkinson's Disease Sheds Light on Old and Novel Disorders of Sphingolipid Metabolism.
Indellicato R; Trinchera M
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284408
[TBL] [Abstract][Full Text] [Related]
18. Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy.
Tringali C; Giussani P
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887154
[TBL] [Abstract][Full Text] [Related]
19. Neurodegenerative Disorders: Spotlight on Sphingolipids.
Mandik F; Vos M
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769423
[TBL] [Abstract][Full Text] [Related]
20. Defective ceramide synthases in mice cause reduced amplitudes in electroretinograms and altered sphingolipid composition in retina and cornea.
Brüggen B; Kremser C; Bickert A; Ebel P; Vom Dorp K; Schultz K; Dörmann P; Willecke K; Dedek K
Eur J Neurosci; 2016 Jul; 44(1):1700-13. PubMed ID: 27086873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
